Mirae Asset Global Etfs Holdings Ltd. Care Dx, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Care Dx, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 112,440 shares of CDNA stock, worth $2.75 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
112,440
Previous 107,543
4.55%
Holding current value
$2.75 Million
Previous $3.36 Million
28.3%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding CDNA
# of Institutions
223Shares Held
54.5MCall Options Held
59.3KPut Options Held
28K-
Black Rock Inc. New York, NY5.29MShares$130 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.86MShares$119 Million0.0% of portfolio
-
State Street Corp Boston, MA2.66MShares$65.1 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.41MShares$59 Million0.45% of portfolio
-
Bamco Inc New York, NY2.21MShares$54.1 Million0.13% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.31B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...